Session 95: AI, Under the Hood
Tuesday, 24th May at 3pm EST, 8pm UK, 9pm CET
This session is sponsored by IVF 2.0
Description: International IVF Initiative I3- Online Session 95-AI, Under The Hood-May 24, 2022
Authors of a recent review article on artificial intelligence, Dr. Charles Bormann and Dr. Irene Dimitriadis co moderated a 90-minute course with colleague Olcay Ocali on deliverable AI solutions in the assisted reproduction technology laboratory.
An introduction by Dr. Jacques Cohen talked about the use of AI already in many other fields of medicine, offering examples and references while stating that AI in an IVF setting is still in its infancy.
He also mentioned concerns and recent guidelines such as transparency, accountability and inclusion that should be central to AI use in medicine.
Dr. Gerardo Mendizaba Ruiz, drawing from his practical experience developing and using AI devices for embryo ranking before embryo selection and also AI to assist the sperm selection prior to ICSI highlighted recent developments in the field. Finally, Dr. Alejandro Chavez Badiola spoke of how AI might influence the decisions of a scientist and discussed the merits of implementing AI as a necessary tool to improve success.
The session was joined by panelists Giles Palmer and Lizeth Barrientos who participated also, together with the speakers and moderators, on the round table discussion centred around AI and from the questions posed by attendees.
Dr. Charles Bormann, Dr. Irene Dimitriadis and Olcay Ocali with panelists Lizeth Barrientos and Giles Palmer
Introduction by Dr. Jacques Cohen
Artificial Intelligence- Lessons from Other Disciplines in Medicine
AI at work: The Mexican Experience
Dr. Gerardo Mendizaba Ruiz
Making your Mind up
Alejandro Chavez Badiola
Round Table Discussion
DR. CHARLES BORMANN
Charles is a reproductive physiologist by training and the Director of the Assisted Reproductive Technology (ART) Laboratory at Massachusetts General Hospital. His clinical responsibilities are focused on managing the ART laboratory and assisting infertile couples conceive by ensuring the safety of their gametes and embryos in vitro, and the provision of optimum conditions for their nurture in culture. These responsibilities require administering stringent quality control and quality assurance programs and implementation of quality improvement programs to maintain the highest standards of care at the forefront of this rapidly evolving field. His specific research interests are using deep-learning AI-technology to help individualize patient care and assist in clinical/laboratory decision making.
DR. IRENE DIMITRIADIS
Her clinical interests include caring for women with infertility, recurrent pregnancy loss, congenital uterine anomalies, polycystic ovarian syndrome, fibroids, uterine polyps, endometriosis and premature ovarian insufficiency, as well as women interested in fertility preservation, preimplantation genetic testing and third-party reproduction. She participates in the care of women requiring assisted reproductive technologies (ART), including ovulation induction and IVF.
Dr. Dimitriadis is also actively involved in research. She has authored articles and presented research projects at national and international conferences. Her prior research has focused on understanding how environmental factors can affect the reproductive system and she was a part of the NIEHS funded EARTH study, collaborating with the Harvard T.H. Chan School of Public Health. Most recently, her research is geared towards understanding and applying the use of deep-learning AI-technology in ART with the goal of individualizing patient care and improving ART outcomes. She loves teaching trainees and believes educating is imperative in moving the field forward.
Olcay had his training in IVF at Yale University Fertility Center where in the Andrology Lab, he also had a chance to work with Dr. Gabor B. Huszar who was the inventor of a novel approach for an improved ICSI sperm selection (PICSI). Olcay later worked at FCNE where he was mentored by embryo grading pioneer Lynette Scott, Ph.D. In Boston IVF he also participates in the research studies with the guidance of another embryology pioneer Denny Sakkas, Ph.D.
Lizeth’s passions are implementation of new technologies in the IVF laboratory that can make the lab team to work more efficiently. She believes that AI in IVF is no longer in the future. It’s here and is going to stay because it will improve the outcomes in the lab to give hope to the IVF patients.
Her work in IVF began in one of the most recognized centers in New York City, New Hope Fertility Center, where she completed all her IVF training. She went to Mexico to NHFC - Guadalajara to be the lab director of one of the first MINI-IVF centers, in the country. She was the Laboratory Consultant at NHFC – Mexico City where she participated and was directly involved in the construction of one of the best IVF Laboratories in Mexico.
Subsequently, she moved to San Diego, California to work as a laboratory supervisor at Hanabusa IVF, where she learned the meticulous laboratory standards and protocols. At the same time, she was also the embryologist lead of Asian Egg Bank.
Lizeth earned her M.Sc. degree from the Monterrey Institute of Technology and Higher Education (ITESM), and hold a B.Sc. degree from the University of Guadalajara.
DR. JACQUES COHEN
He was one of the founders of Alpha – Scientists in Reproductive Medicine and one of the founders of Preimplantation Genetic Diagnosis International Society - PGDIS. He is a founding member of the International IVF Initiative.
Jacques Cohen was born in The Hague, The Netherlands and graduated in Biology of Reproductive Science in 1978 at Leiden University, Leiden, The Netherlands. He has a Ph.D. from Erasmus University in Rotterdam (supervisor Prof. Gerard Zeilmaker), in aspects of in vitro fertilization and male factor infertility. His postdoctoral studies (1982-1985) were performed at Cambridge University (UK) and Bourn Hall Clinic (supervisor Prof Robert Edwards). Jacques Cohen has (co-)developed a number of embryological methodologies and devices: blastocyst cryopreservation, assisted fertilization, assisted hatching, preimplantation genetic testing, ooplasmic donation, single sperm freezing, CODA filtration, Global media, and GPS dishes. He currently serves on Advisory Boards of biotech startups TMRW, Kindbody, DADI and Phosphorus.
DR. GERARDO MENDIZABA RUIZ
DR. ALEJANDRO CHAVEZ BADIOLA
Founder and Chief Medical Officer at the New Hope Fertility Mexico since 2009
Appointed as Professor and Research Coordinator, Clinical Sciences Division, Health Sciences, Universidad de Guadalajara, Mexico (2007)
Training in Reproductive Medicine at the Hewitt Centre for Reproductive Medicine, Liverpool Women’s Hospital (2005-2007)
Entered in the British General Medical Council (GMC) Registry in 2005
Received the Highly Skilled Specialist Sponsorship by The British Council (2004)
Training in Obstetrics and Gynaecology at Hospital Civil, Guadalajara. Appointed as Chief Resident in Obstetrics and Gynaecology twice in this period (2000-2004)
Graduated with Honours from Medical School at Universidad de Guadalajara, Mexico (1998).